Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer
Condition(s):Advanced or Metastatic Breast CancerLast Updated:November 22, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Advanced or Metastatic Breast CancerLast Updated:November 22, 2023Completed
Condition(s):Cystic Tumors of the PancreasLast Updated:July 26, 2016Unknown status
Condition(s):Mucinous Cystic Tumor With Moderate Dysplasia; Mucinous Cystadenoma of Pancreas; Mucinous Cystadenocarcinoma of Pancreas; Benign Neoplasm of PancreasLast Updated:November 2, 2016Terminated
Condition(s):Pancreatic Cyst; Pancreatic Intraductal Papillary-Mucinous Neoplasm; Cystadenoma, Mucinous; Papillary Mucinous Cystadenoma, Borderline MalignancyLast Updated:April 14, 2022Completed
Condition(s):CancerLast Updated:February 10, 2009Completed
Condition(s):Breast NeoplasmLast Updated:June 4, 2009Terminated
Condition(s):Cervical CancerLast Updated:November 22, 2023Withdrawn
Condition(s):Stricture UrethraLast Updated:January 10, 2023Recruiting
Condition(s):Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell CarcinomaLast Updated:February 8, 2024Not yet recruiting
Condition(s):Recurrent Platinum-resistant Ovarian CancerLast Updated:December 8, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.